Authors:
FALKON L
GARI M
BARBANOJ M
AMIRAL J
FONTCUBERTA J
Citation: L. Falkon et al., TISSUE FACTOR PATHWAY INHIBITOR AND ANTI-FXA KINETIC PROFILES OF A NEW LOW-MOLECULAR-MASS HEPARIN, BEMIPARIN, AT THERAPEUTIC SUBCUTANEOUS DOSES, Blood coagulation & fibrinolysis, 9(2), 1998, pp. 137-141
Authors:
GISPERT J
ANTONIJOAN R
BARBANOJ M
GICH I
MORTE A
GARCIA E
ESBRI R
LURIA X
Citation: J. Gispert et al., PHARMACODYNAMIC ASSESSMENT OF THE EFFICACY OF SINGLE AND MULTIPLE DOSES OF EBASTINE, CETIRIZINE AND LORATADINE AGAINST HISTAMINE-INDUCED CUTANEOUS CHALLENGE IN HEALTHY-VOLUNTEERS, Journal of allergy and clinical immunology, 101(1), 1998, pp. 920-920
Authors:
KULISEVSKY J
GARCIASANCHEZ C
LOPEZVILLEGAS D
BERTHIER ML
GIRONELL A
BARBANOJ M
PASCUALSEDANO B
Citation: J. Kulisevsky et al., CHRONIC EFFECTS OF DOPAMINERGIC REPLACEMENT ON COGNITIVE FUNCTION IN PARKINSONS-DISEASE - A ONE-YEAR FOLLOW-UP-STUDY ON UNTREATED PATIENTS COMPARING LEVODOPA AND PERGOLIDE, Neurology, 50(4), 1998, pp. 5041-5041
Authors:
GIRONELL A
KULISEVSKY J
BARBANOJ M
LOPEZVILLEGAS D
HERNANDEZ G
PASCUALSEDANO B
Citation: A. Gironell et al., A DOUBLE-BLIND PLACEBO-CONTROLLED COMPARATIVE TRIAL OF GABAPENTIN ANDPROPRANOLOL IN PATIENTS WITH ESSENTIAL TREMOR, Neurology, 50(4), 1998, pp. 7006-7006
Authors:
ARROYO C
LOPEZCALULL C
GARCIACAPDEVILA L
GICH I
BARBANOJ M
BONAL J
Citation: C. Arroyo et al., DETERMINATION OF CAPTOPRIL IN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY FOR PHARMACOKINETIC STUDIES, Journal of chromatography B. Biomedical sciences and applications, 688(2), 1997, pp. 339-344
Authors:
BALLESTER M
MARTI V
CARRIO I
OBRADOR D
MOYA C
PONSLLADO G
BERNA L
LAMICH R
AYMAT MR
BARBANOJ M
GUARDIA J
CARRERAS F
UDINA C
AUGE JM
MARRUGAT J
PERMANYER G
CARALPSRIERA JM
Citation: M. Ballester et al., SPECTRUM OF ALCOHOL-INDUCED MYOCARDIAL DAMAGE DETECTED BY INDIUM-111-LABELED MONOCLONAL ANTIMYOSIN ANTIBODIES, Journal of the American College of Cardiology, 29(1), 1997, pp. 160-167
Authors:
FALKON L
GARI M
BARBANOJ M
AMIRAL J
FONTCUBERTA J
Citation: L. Falkon et al., TFPI AND ANT-FXA KINETIC PROFILES OF A NEW LMMH (RO-11.ROVI), AT SC THERAPEUTIC DOSES, Thrombosis and haemostasis, 1997, pp. 1173-1173
Authors:
FALKON L
BAYES M
FRONTERA G
GARI M
BARBANOJ M
FONTCUBERTA J
Citation: L. Falkon et al., PHARMACOKINETICS AND TOLERABILITY OF A NEW LOW-MOLECULAR-MASS HEPARIN(RO-11) IN HEALTHY-VOLUNTEERS - A DOSE-FINDING STUDY WITHIN THE THERAPEUTIC RANGE, Thrombosis and haemostasis, 77(1), 1997, pp. 133-136
Authors:
HERNANDEZCOLLADOS A
SANCHEZTURET M
ARNAU J
GARCIAGEA C
BARBANOJ M
Citation: A. Hernandezcollados et al., THE HIGHER MOTOR-PERFORMANCE OF THE DOMINANT HAND TENDS TO DISAPPEAR UNDER ALCOHOL EFFECTS, International journal of psychophysiology, 25(1), 1997, pp. 45-45
Authors:
HERNANDEZCOLLADOS A
SANCHEZTURET M
ANTONIJOAN R
MASSANA E
BARBANOJ M
Citation: A. Hernandezcollados et al., TIME PERCEPTION IS DISTORTED UNDER ALCOHOL EFFECTS, EVEN AT BAC VALUENEAR TO ZERO, International journal of psychophysiology, 25(1), 1997, pp. 45-46
Authors:
GIRONELL A
KULISEVSKY J
BARBANOJ M
ANTONIJOAN R
MASSANA E
Citation: A. Gironell et al., QUANTITATIVE ASSESSMENT OF PARKINSONS-DISEASE TREMOR RESPONSE TO THEOPHYLLINE AND PLACEBO - A DOUBLE-BLIND RANDOMIZED CROSSOVER STUDY, Neurology, 48(3), 1997, pp. 3093-3093
Authors:
SAENZCAMPOS D
BAYES MC
MASANA E
MARTIN S
BARBANOJ M
JANE F
Citation: D. Saenzcampos et al., SEX-RELATED PHARMACOKINETIC AND PHARMACODYNAMIC VARIATIONS OF LISINOPRIL, Methods and findings in experimental and clinical pharmacology, 18(8), 1996, pp. 533-538
Authors:
KULISEVSKY J
AVILA A
BARBANOJ M
ANTONIJOAN R
BERTHIER ML
Citation: J. Kulisevsky et al., NEUROPSYCHOLOGICAL PERFORMANCE IN STABLE AND FLUCTUATING PARKINSONS-DISEASE PATIENTS AT 3 DIFFERENT LEVODOPA PLASMA-LEVELS, Neurology, 46(2), 1996, pp. 1098-1098
Authors:
KULISEVSKY J
AVILA A
BARBANOJ M
ANTONIJOAN R
BERTHIER ML
GIRONELL A
Citation: J. Kulisevsky et al., ACUTE EFFECTS OF LEVODOPA ON NEUROPSYCHOLOGICAL PERFORMANCE IN STABLEAND FLUCTUATING PARKINSONS-DISEASE PATIENTS AT DIFFERENT LEVODOPA PLASMA-LEVELS, Brain, 119, 1996, pp. 2121-2132
Authors:
KULISEVSKY J
AVILA A
BARBANOJ M
ANTONIJOAN R
TORRES J
ARCELUS R
Citation: J. Kulisevsky et al., LEVODOPA DOES NOT AGGRAVATE POSTURAL TREMOR IN PARKINSONS-DISEASE, Clinical neuropharmacology, 18(5), 1995, pp. 435-442
Authors:
FALKON L
SAENZCAMPOS D
GARI M
ANTONIJOAN R
BARBANOJ M
FONTCUBERTA J
Citation: L. Falkon et al., KINETIC-BEHAVIOR OF THE TFPI AND ANTI-FXA EFFECTS, AFTER THE INJECTION OF A NEW LMWH (RO-11) IN HEALTHY-SUBJECTS, Thrombosis and haemostasis, 73(6), 1995, pp. 971-971
Authors:
FALKON L
GARI M
SAENZCAMPOS D
ANTONIJOAN R
BARBANOJ M
FONTCUBERTA J
Citation: L. Falkon et al., KINETIC-BEHAVIOR OF THE TFPI AND ANTI-FXA EFFECTS, AFTER THE INJECTION OF A LMWH (RO-11) IN HEALTHY-SUBJECTS, Thrombosis and haemostasis, 73(4), 1995, pp. 728-729
Authors:
FALKON L
SAENZCAMPOS D
ANTONIJOAN R
MARTIN S
BARBANOJ M
FONTCUBERTA J
Citation: L. Falkon et al., BIOAVAILABILITY AND PHARMACOKINETICS OF A NEW LOW-MOLECULAR-WEIGHT HEPARIN (RO-11) - A 3-WAY CROSS-OVER STUDY IN HEALTHY-VOLUNTEERS, Thrombosis research, 78(1), 1995, pp. 77-86
Authors:
SANCHEZ R
BARBANOJ M
FERNANDEZTERUEL A
ESCORIHUELA RM
TOBENA A
Citation: R. Sanchez et al., EFFECTS OF BENZODIAZEPINE AGONISTS AND ANTAGONISTS ON THE PROCESS OF HABITUATION DURING EXPOSURE TREATMENTS, Neuropsychopharmacology, 9(2), 1993, pp. 190000123-190000123